Vaxcyte Stock Price on November 12, 2024
| PCVX Stock | USD 91.70 3.16 3.57% |
Below is the normalized historical share price chart for Vaxcyte extending back to June 12, 2020. This chart has been adjusted for all splits and dividends and is plotted against all major global economic recessions. As of today, the current price of Vaxcyte stands at 91.70, as last reported on the 26th of November, with the highest price reaching 92.15 and the lowest price hitting 89.06 during the day.
If you're considering investing in Vaxcyte Stock, it is important to understand the factors that can impact its price. Vaxcyte appears to be very steady, given 3 months investment horizon. Vaxcyte owns Efficiency Ratio (i.e., Sharpe Ratio) of 0.0699, which indicates the firm had a 0.0699% return per unit of risk over the last 3 months. We have found twenty-nine technical indicators for Vaxcyte, which you can use to evaluate the volatility of the company. Please review Vaxcyte's Coefficient Of Variation of 1699.94, risk adjusted performance of 0.0536, and Semi Deviation of 2.19 to confirm if our risk estimates are consistent with your expectations.
At this time, Vaxcyte's Total Stockholder Equity is fairly stable compared to the past year. Common Stock is likely to rise to about 102.9 K in 2024, whereas Common Stock Shares Outstanding is likely to drop slightly above 57.4 M in 2024. . At this time, Vaxcyte's Price Book Value Ratio is fairly stable compared to the past year. Price To Book Ratio is likely to rise to 5.16 in 2024, whereas Price Earnings Ratio is likely to drop (15.93) in 2024. Vaxcyte Stock price history is provided at the adjusted basis, taking into account all of the recent filings.
IPO Date 12th of June 2020 | 200 Day MA 83.2085 | 50 Day MA 107.8906 | Beta 1.009 |
Vaxcyte |
Sharpe Ratio = 0.0699
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | PCVX | |||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns |
Estimated Market Risk
| 5.12 actual daily | 45 55% of assets are more volatile |
Expected Return
| 0.36 actual daily | 7 93% of assets have higher returns |
Risk-Adjusted Return
| 0.07 actual daily | 5 95% of assets perform better |
Based on monthly moving average Vaxcyte is performing at about 5% of its full potential. If added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Vaxcyte by adding it to a well-diversified portfolio.
Price Book 3.2289 | Book Value 27.466 | Enterprise Value 8.9 B | Enterprise Value Ebitda (14.43) | Shares Float 115.5 M |
Vaxcyte Valuation on November 12, 2024
It is possible to determine the worth of Vaxcyte on a given historical date. On November 12, 2024 Vaxcyte was worth 102.06 at the beginning of the trading date compared to the closed value of 99.38. We use multiple weighted factors in our valuation methodologies to arrive at the intrinsic value of Vaxcyte stock. Still, in general, we apply an absolute valuation method to find Vaxcyte's value based on its fundamental and technical indicators available within our service. As compared to an absolute model, our relative valuation model uses a comparative analysis of Vaxcyte where we calculate exposure to its market risk and evaluate relevant financial multiples and ratios against Vaxcyte's related companies.
| Open | High | Low | Close | Volume | |
| 106.67 | 107.22 | 102.83 | 103.64 | 875,326 | |
11/12/2024 | 102.06 | 103.30 | 98.68 | 99.38 | 1,550,434 |
| 100.26 | 100.68 | 94.00 | 96.63 | 2,853,325 |
| Backtest Vaxcyte | | | Vaxcyte History | | | Vaxcyte Valuation | Previous | Next |
Vaxcyte Trading Date Momentum on November 12, 2024
| On November 13 2024 Vaxcyte was traded for 96.63 at the closing time. The top price for the day was 100.68 and the lowest listed price was 94.00 . The trading volume for the day was 2.9 M. The trading history from November 13, 2024 was a factor to the next trading day price decrease. The trading delta at closing time against the next closing price was 2.77% . The trading price change against the current closing price is 11.04% . |
Vaxcyte Fundamentals Correlations and Trends
By evaluating Vaxcyte's financials over time, investors can gain insight into future company performance. However, you can also analyze the published financial statements to find patterns among Vaxcyte's main balance sheet or income statement drivers and many other relevant indicators that can statistically be found significantly correlated or uncorrelated. Vaxcyte financial account trend analysis is a perfect complement when working with valuation or volatility modules.About Vaxcyte Stock history
Vaxcyte investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for Vaxcyte is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in Vaxcyte will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing Vaxcyte stock prices may prove useful in developing a viable investing in Vaxcyte
| Last Reported | Projected for Next Year | ||
| Common Stock Shares Outstanding | 97.2 M | 57.4 M | |
| Net Loss | -201.1 M | -191.1 M |
Vaxcyte Quarterly Net Working Capital |
|
Vaxcyte Stock Technical Analysis
Vaxcyte technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
Price Boundaries
Vaxcyte Period Price Range
Low | November 26, 2024
| High |
0.00 | 0.00 |
Vaxcyte cannot be verified against its exchange. Please verify the symbol is currently traded on NASDAQ Exchange. If you still believe the symbol you are trying to look up is valid, please let us know, and we will check it as soon as possible.
Vaxcyte November 26, 2024 Market Strength
Market strength indicators help investors to evaluate how Vaxcyte stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Vaxcyte shares will generate the highest return on investment. By undertsting and applying Vaxcyte stock market strength indicators, traders can identify Vaxcyte entry and exit signals to maximize returns
Vaxcyte Technical and Predictive Indicators
Predictive indicators are helping investors to find signals for Vaxcyte's price direction in advance. Along with the technical and fundamental analysis of Vaxcyte Stock historical price patterns, it is also worthwhile for investors to track various predictive indicators of Vaxcyte to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.
| Risk Adjusted Performance | 0.0536 | |||
| Jensen Alpha | 0.4067 | |||
| Total Risk Alpha | (0.50) | |||
| Sortino Ratio | 0.0653 | |||
| Treynor Ratio | (0.28) |
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
Additional Tools for Vaxcyte Stock Analysis
When running Vaxcyte's price analysis, check to measure Vaxcyte's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Vaxcyte is operating at the current time. Most of Vaxcyte's value examination focuses on studying past and present price action to predict the probability of Vaxcyte's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Vaxcyte's price. Additionally, you may evaluate how the addition of Vaxcyte to your portfolios can decrease your overall portfolio volatility.